definiens: means, with respect to a particular Collaboration Product, one or more Third Party product(s ) ( i ) having thesame active pharmaceutical ingredient as such Collaboration Product and for which in the U.S. an ANDA has been filednaming such Collaboration Product as the reference listed drug or outside of the U.S., an equivalent process wherebioequivalence to such Collaboration Product has been asserted, and ( ii ) such Third Party product(s ) when taken in theaggregate have a market share ( measured in number of prescriptions with the numerator of such fractional share being suchThird Party product(s ) taken in the aggregate, and the denominator being the total of such Third Party product(s ) taken in theaggregate plus such Collaboration Product taken in the aggregate, as provided by IMS ) during the applicable CalendarQuarter in such country of at least [ * * * ] %